Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham J Mann

Showing results (111-120 of 183) with videos related to

Pageof 19
Sort By:
Life Science Alliance|March 21, 2023
Cell death and barrier disruption by clinically used iodine concentrationsAnne Steins, Christina Carroll, Fui Jiun Choong, et al.
Ebiomedicine|August 20, 2015
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisMitchell S Stark, Kerenaftali Klein, Benjamin Weide, et al.
Contemporary Clinical Trials|May 27, 2018
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviorsAmelia K Smit, Ainsley J Newson, Rachael L Morton, et al.
BMJ Open|March 1, 2020
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods studyFrances Rapport, Andrea L Smith, Anne E Cust, et al.
BMC Cancer|October 19, 2013
MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family studyAnne E Cust, Chris Goumas, Kylie Vuong, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Journal of the National Cancer Institute|February 7, 2002
Dominant negative ATM mutations in breast cancer familiesGeorgia Chenevix-Trench, Amanda B Spurdle, Magtouf Gatei, et al.
Carcinogenesis|January 8, 2013
Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma riskHongliang Liu, Li-E Wang, Zhensheng Liu, et al.
The Journal of Investigative Dermatology|June 12, 2018
Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based StudiesAnne E Cust, Martin Drummond, Peter A Kanetsky, et al.
Pageof 19

Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Life Science Alliance|March 21, 2023
Cell death and barrier disruption by clinically used iodine concentrationsAnne Steins, Christina Carroll, Fui Jiun Choong, et al.
Ebiomedicine|August 20, 2015
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression AnalysisMitchell S Stark, Kerenaftali Klein, Benjamin Weide, et al.
Contemporary Clinical Trials|May 27, 2018
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviorsAmelia K Smit, Ainsley J Newson, Rachael L Morton, et al.
BMJ Open|March 1, 2020
Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: protocol paper for a mixed methods studyFrances Rapport, Andrea L Smith, Anne E Cust, et al.
BMC Cancer|October 19, 2013
MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family studyAnne E Cust, Chris Goumas, Kylie Vuong, et al.
Pathology|October 31, 2015
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomesJames S Wilmott, Matthew A Field, Peter A Johansson, et al.
The Journal of Investigative Dermatology|February 18, 2019
Molecular Genomic Profiling of Melanocytic NeviAndrew J Colebatch, Peter Ferguson, Felicity Newell, et al.
Journal of the National Cancer Institute|February 7, 2002
Dominant negative ATM mutations in breast cancer familiesGeorgia Chenevix-Trench, Amanda B Spurdle, Magtouf Gatei, et al.
Carcinogenesis|January 8, 2013
Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma riskHongliang Liu, Li-E Wang, Zhensheng Liu, et al.
The Journal of Investigative Dermatology|June 12, 2018
Assessing the Incremental Contribution of Common Genomic Variants to Melanoma Risk Prediction in Two Population-Based StudiesAnne E Cust, Martin Drummond, Peter A Kanetsky, et al.
Pageof 19